Weight change and clinical markers of cardiovascular disease risk during preventive treatment of migraine

Cephalalgia

Volumn 29, Issue 11, 2009, Pages 1188-1196

  Bigal, Me ^a,b   Lipton, Rb ^b   Biondi, Dm ^c   Xiang, J ^c   Hulihan, J ^c  

^a MERCK RESEARCH LABORATORIES   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^c JANSSEN RESEARCH AND DEVELOPMENT   (United States)

Author keywords

Amitriptyline; Cardiovascular disease; Migraine; Topiramate; Weight change

Indexed keywords

AMITRIPTYLINE; C REACTIVE PROTEIN; CHOLESTEROL; GLYCOSYLATED HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TOPIRAMATE; TRIACYLGLYCEROL;

ADULT; ARTICLE; BODY WEIGHT; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DOUBLE BLIND PROCEDURE; FEMALE; HEART RATE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIGRAINE; SYSTOLIC BLOOD PRESSURE; TREATMENT RESPONSE; WEIGHT CHANGE; WEIGHT GAIN;

ADULT; AMITRIPTYLINE; ANALGESICS, NON-NARCOTIC; BIOLOGICAL MARKERS; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; CHOLESTEROL, HDL; DOUBLE-BLIND METHOD; FEMALE; FRUCTOSE; HUMANS; MALE; MIGRAINE DISORDERS; RISK FACTORS; WEIGHT GAIN; WEIGHT LOSS;

EID: 70349667442     PISSN: 03331024     EISSN: 14682982     Source Type: Journal    
DOI: 10.1111/j.1468-2982.2009.01853.x     Document Type: Article

References (40)

1. Lipton RB, Bigal ME, Diamond M, Freitag F, Reed ML, Stewart WF. Migraine prevalence, disease burden, and the need for preventive therapy. Neurology 2007 68 : 343 9.
2. Leonardi M, Steiner TJ, Scher AT, Lipton RB. The global burden of migraine: measuring disability in headache disorders with WHO's Classification of Functioning, Disability and Health (ICF). J Headache Pain 2005 6 : 429 440.
3. Ogden CL, Carroll MD, Curtin LR, McDowell MA, Tabak CJ, Flegal KM. Prevalence of overweight and obesity in the United States, 1999-2004. JAMA 2006 295 : 1549 55.
4. Center for Disease Control and Prevention. State-specific prevalence of obesity among adults - United States, 2005. MMWR 2006 55 : 985 88.
5. Kurth T, Slomke MA, Kase CS, Cook NR, Lee IM, Gaziano JM et al. Migraine, headache, and the risk of stroke in women: a prospective study. Neurology 2005 64 : 1020 1026. (Pubitemid 40388455)
6. Kurth T, Gaziano JM, Cook NR, Logroscino G, Diener HC, Buring JE. Migraine and risk of cardiovascular disease in women. JAMA 2006 296 : 283 291. Erratum in: JAMA 2006; 296:654 and JAMA 2006; 296:1 p following 291.
7. Kurth T, Gaziano JM, Cook NR, Bubes V, Logroscino G, Diener HC, Buring JE. Migraine and risk of cardiovascular disease in men. Arch Intern Med 2007 167 : 795 801. (Pubitemid 46658337)
8. Kurth T. Migraine and ischaemic vascular events. Cephalalgia 2007 27 : 967 975.
9. Velentgas P, Cole JA, Mo J, Sikes CR, Walker AM. Severe vascular events in migraine patients. Headache 2004 44 : 642 651.
10. Scher AI, Terwindt GM, Picavet HS, Verschuren WM, Ferrari MD, Launer LJ. Cardiovascular risk factors and migraine: the GEM population-based study. Neurology 2005 64 : 614 620.
11. Stang PE, Carson AP, Rose KM, Mo J, Ephross SA, Shahar E, Szklo M. Headache, cerebrovascular symptoms, and stroke: the Atherosclerosis Risk in Communities Study. Neurology 2005 64 : 1573 1577. (Pubitemid 40617693)
12. National Institutes of Health. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults. NIH Publication No. 98-4083. 1998 WWW document]. URL http://www.ncbi.nlm.nih.gov/books/bv.fcgi? rid=obesity (accessed November 2007).
13. Bigal ME, Liberman JN, Lipton RB. Obesity and migraine. A population study. Neurology 2006 66 : 545 550.
14. Scher AI, Stewart WF, Ricci JA, Lipton RB. Factors associated with the onset and remission of chronic daily headache in a population-based study. Pain 2003 106 : 81 9.
15. Bigal ME, Lipton RB. Obesity is a risk factor for transformed migraine but not chronic tension-type headache. Neurology 2006 67 : 252 257.
16. Bigal ME, Tsang A, Loder E, Serrano D, Reed ML, Lipton RB. Body mass index and episodic headaches: a population-based study. Arch Intern Med 2007 167 : 1964 1970.
17. Ness-Abramof R, Apovian CM. Drug-induced weight gain. Drugs Today (Barc) 2005 41 : 547 55.
18. Young WB, Rozen TD. Preventive treatment of migraine: effect on weight. Cephalalgia 2005 25 : 1 11.
19. Vanina Y, Podolskaya A, Sedky K, Shahab H, Siddiqui A, Munshi F, Lippmann S. Body weight changes associated with psychopharmacology. Psychiatr Serv 2002 53 : 842 847.
20. Brandes JL, Saper JR, Diamond M, Couch JR, Lewis DW, Schmitt J et al., MIGR-002 Study Group. Topiramate for migraine prevention: a randomized controlled trial. JAMA 2004 291 : 965 973. (Pubitemid 38543754)
21. Silberstein SD, Neto W, Scmitt J, Jacobs D. Topiramate in migraine prevention: results from a large controlled trial. Arch Neurol 2004 61 : 490 495. (Pubitemid 38923736)
22. Diener HC, Tfelt-Hansen P, Dahlof C, Lainez MJ, Sandrini G, Wang SJ et al. Topiramate in migraine prophylaxis - results from a placebo-controlled trial with propranolol as an active control. J Neurol 2004 251 : 943 950.
23. Drake ME Jr., Renner NI, Greathouse JB, Armentbright AD. Open-label zonisamide for refractory migraine. Clin Neuropharmacol 2004 27 : 278 280.
24. Silberstein SD, Collins SD. Safety of divalproex sodium in migraine prophylaxis: an open-label, long-term study. Long-term Safety of Depakote in Headache Prophylaxis Study Group. Headache 1999 39 : 633 643.
25. Maggioni F, Ruffatti S, Dainese F, Mainardi F, Zanchin G. Weight variations in the prophylactic therapy of primary headaches: 6-month follow-up. J Headache Pain 2005 6 : 322 324.
26. Dodick D, Silberstein S, Freitag F, Ruoff G, Banks J, Saper J et al. Topiramate versus amitriptyline for migraine prophylaxis: a multicenter, randomized, double-blind, parallel treatment group trial. Presented at the 59th American Academy of Neurology Annual Meeting; April 28-May 5, 2007; Boston, MA. Poster P08.001.
27. Headache Classification Subcommittee of the International Headache Society. The International Classification of Headache Disorders, 2nd edn. Cephalagia 2004 24 (Suppl. 1 1 160.
28. Tfelt-Hansen P, Block G, Dahlof C, Diener HC, Ferrari MD, Goadsby PJ et al. Guidelines for controlled trials of drugs in migraine: second edition. Cephalalgia 2000 20 : 765 86.
29. US Department of Health and Human Services. National high blood pressure education program. NIH Publication No. 03-5231. May 2003.
30. Third Report of the National Cholesterol Education Program (NCEP). Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). NIH. [WWW document]. URL http://www.nhlbi.nih.gov/guidelines/cholesterol/index.htm (accessed 28 August, 2007).
31. Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO 3rd., Criqui M et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 2003 107 : 499 511.
32. Bigal ME, Gironda M, Tepper SJ, Feleppa M, Rapoport AM, Sheftell FD, Lipton RB. Headache prevention outcome and body mass index. Cephalalgia 2006 26 : 445 450.
33. Ashley FW Jr., Kannel WB. Relation of weight change to changes in atherogenic traits: the Framingham Study. J Chronic Dis 1974 27 : 103 114.
34. Denke MA, Sempos CT, Grundy SM. Excess body weight. An underrecognized contributor to high blood cholesterol levels in white American men. Arch Intern Med 1993 153 : 1093 1103.
35. Hershcopf RJ, Elahi D, Andres R, Baldwin HL, Raizes GS, Schocken DD, Tobin JD. Longitudinal changes in serum cholesterol in man: an epidemiologic search for an etiology. J Chronic Dis 1982 35 : 101 114.
36. Lee YH, Pratley RE. The evolving role of inflammation in obesity and the metabolic syndrome. Curr Diab Rep 2005 5 : 70 5.
37. Welch KMA, Brandes AW, Salerno L, Brandes JL. C-reactive protein may be increased in migraine patients who present with complex clinical features. Headache 2006 46 : 197 199.
38. Vanmolkot FH, de Hoon JN. Increased C-reactive protein in young adult patients with migraine. Cephalalgia 2007 27 : 843 846.
39. Waeber C, Moskowitz MA. Migraine as an inflammatory disorder. Neurology 2005 64 (Suppl. 2 S9 15.
40. World Health Organization. Cardiovascular diseases prevention and control. 2003 WWW document]. URL http://www.who.int/dietphysicalactivity/ publications/facts/cvd/en/print.html (accessed 28 August 2007).